Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Chugai licenses diabetes project CSG452 to Kowa, Sanofi

Executive Summary

Roche unit Chugai Pharmaceutical Co. Ltd. has granted Sanofi KK and Kowa Co. Ltd. rights to develop and co-market the Type II diabetes compound CSG452 in Japan.

Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Marketing
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register